Anti-CCP2 concentrations at baseline (month 0 (M0)), 1 year (M12) and 3 years (M36) of follow-up according to decreasing concentrations (panel 1 and 2), increasing concentrations (panel 1 and 2) or steady concentrations

<b>Copyright information:</b>Taken from "Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis"Arthritis Research &amp; Therapy 2006;8(2):R40-R40.Published online 26 Jan 2006PMCID:PMC1526612. Patients with transition from positive to negative and negative to positive are shown on panel 2 in (a, b).